Company page
Cytogen, Inc.
Cytogen, Inc. is a public company traded under the ticker 217330 in the Korean market. The company has a market capitalization of approximately 60.56 million USD. Cytogen focuses on developing innovative solutions in its industry, contributing to advancements in technology and services.
- Ticker
- 217330:KRX
- Asset type
- Stock
- Market cap
- $60.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW